AmerisourceBergen Corp ABC:NYSE
Education help is ON
Sector: Healthcare Industry: Biotechnology & Drugs
24.49 Arrow Up0.28   1.16% 4,907,262 Market data is delayed by at least 20 minutes.
Last Change  /  % Change Volume
Exclusive
Features
 
When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes. Or
 
1day |  5day |  6mo |  1yr |  5yr

Latest News Headlines for AmerisourceBergen Corp

Friday 11/20/2009 4:04 AM ET - Investrend

(Comment on this article at (Click Here) 20, 2009 (FinancialWire) -- AmerisourceBergen Corp. (NYSE: ABC) has completed its public offering of $400 million principal amount of 4.875% senior notes due November 15, 2019. The company plans to use approximately $221.9 million of the net proceeds from this offering to repay substantially all the amounts outstanding under its multi-currency rev

Thursday 11/19/2009 1:06 PM ET - BusinessWire

AmerisourceBergen Corporation (NYSE: ABC) today announced it had completed its public offering of $400 million principal amount of 4.875% Senior Notes due November 15, 2019. AmerisourceBergen intends to use approximately $221.9 million of the net proceeds from this offering to repay substantially all the amounts outstanding under its multi-currency revolving credit facility. The remainder of the proceeds will be used for general corporate purposes.

Thursday 11/19/2009 12:31 PM ET - FreshBrewedMedia

AmerisourceBergen (ABC) was upgraded today by analysts at UBS and the stock is now at $24.19, down $0.20 (-0.82%) on volume of 1,298,387 shares traded. UBS has lifted its rating on the stock to Buy from Neutral. Over the last 52 weeks the stock has ranged from a low of $13.33 in last November to a high of $24.85 in earlier this month. AmerisourceBergen stock has been showing support around $23.96 and resistance in the $24.78 range. Technical indicators for the stock are bullish and S&P gi

Thursday 11/19/2009 10:26 AM ET - Comtex SmarTrend(R)

AmerisourceBergen (NYSE:ABC) initiated as Buy at UBS. The stock closed yesterday at $24.47 on volume of 2,873,400 shares, below average daily volume of 2,966,869.

AmerisourceBergen is currently above its 50-day moving average of $22.67 and above its 200-day moving average of $19.23.

Thursday 11/19/2009 8:45 AM ET - Comtex SmarTrend(R)

Analyst Upgrades for 11/19/2009... AmerisourceBergen (NYSE:ABC) initiated as Buy at UBS... AvalonBay Communities (NYSE:AVB) upgraded to Outperform at RBC... Cardinal Health (NYSE:CAH) initiated as Buy at UBS... Chicos (NYSE:CHS) reiterated Outperform, raised price target to $18 from $15, at FBR... CLARCOR (NYSE:CLC) upgraded to Buy, $40 target, at BB&T... CNA Financial (NYSE:CAN) upgraded to Buy, $27 target, at BofA/Merrill... CVS Caremark (NYSE:CVS) initiated as Buy at UBS... Endurance S

Earlier Headlines - view recent headlines
--/--

Bid/Size

--/--

Ask/Size

24.19

Price Open

24.21

Previous Close

24.70

Day High

24.17

Day Low

0.73

Beta (5yr)

24.85/11/16/09

52wk High/Date

13.33/11/21/08

52wk Low/Date

7.3 Billion

Market Capitalization

297.3 Million

Shares Outstanding

30.85

Volatility Avg (1 Year)

2.9 Million

Avg Vol (10 day)

14.5x

P/E Ratio

1.68

EPS (TTM)

0.08 (12/7/09)

Declared QRTR Div explain

1.31%

Yield

11/19/2009

Ex-Date

Scottrade Customers

Get the following exclusive content at no additional cost with your Scottrade account:

  • Standard & Poor's STARS Rating for the featured stock
  • Research reports from Reuters and Standard & Poor's
  • Market Edge Second Opinion Weekly Report

For full analysis, Open an Account or Log In with Scottrade

Amerisourcebergen Corp vs. Peers

Company Market Cap YTD Price Performance
ABC

AmerisourceBergen Corp

7.3B
+37.4%
CAH

Cardinal Health, Inc.

11.5B
+28.4%
MCK

McKesson Corporation

16.9B
+63.0%
HSIC

Henry Schein, Inc.

4.6B
+37.7%
ESRX

Express Scripts, Inc.

23.4B
+54.8%

Company Background

AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations in the United States, Canada and the United Kingdom. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. It distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, institutional pharmacies, mail order facilities, physicians, medical clinics, alternate site facilities and other customers. AmerisourceBergen also provides pharmaceuticals and pharmacy services to workers' compensation and specialty drug patients. The Company operates in two business segments: Pharmaceutical Distribution and Other.

© 2008 Scottrade

Brokerage Products and Services offered by Scottrade, Inc. - Member FINRA and SIPC

Online market and limit stock trades are just $7 for stocks priced $1 and above.

Any specific securities, or types of securities, used as examples are for demonstration purposes only. No information on this Web site should be considered a recommendation or None of the information provided should be considered a recommendation or solicitation to invest in, or liquidate, a particular security or type of security.

Investors should consider the investment objectives, risks, and charges and expenses of a mutual fund carefully before investing. A mutual fund's prospectus contains this and other information about the mutual fund. Prospectuses are available through our trading site or through a Scottrade branch office. The prospectus should be read carefully before investing. No transaction fee (NTF) funds are subject to the terms and conditions of the NTF funds program. Scottrade is compensated by the funds participating in the NTF program through recordkeeping, shareholder, or SEC 12b-1 fees.

Investors should consider the investment objectives, charges, expense, and unique risk profile of an Exchange Traded Fund (ETF) carefully before investing. Leveraged and Inverse ETFs may not be suitable for long-term investors and may increase exposure to volatility through the use of leverage, short sales of securities, derivatives and other complex investment strategies. A prospectus contains this and other information about the ETF and should be obtained from the issuer. The prospectus should be read carefully before investing.

Margin trading involves interest charges and risks, including the potential to lose more than deposited, or the need to deposit additional collateral in a falling market. Margin Disclosure Statement (PDF) is available for download, or it is available at one of our branch offices. It contains information on our lending policies, interest charges, and the risks associated with margin accounts.

Options involve risk and are not appropriate for all investors. Detailed information about the risks associated with options can be found in the Scottrade Options Application and Agreement, Brokerage Account Agreement, or by downloading the Characteristics and Risks of Standardized Options and Supplements (PDF) from The Options Clearing Corporation, or by requesting a copy from your local branch office. Supporting documentation for any claims will be supplied upon request.

Market volatility, volume, and system availability may impact account access and trade execution.

Testimonials may not be representative of the experience of other clients and are no guarantee of future performance or success.